PuraCath UV Device Displays a 99.9999% Disinfection of COVID-19 Virus in 1 Second
PuraCath has been partnered and working with a top tier BSL-3 National Laboratory, which has a premiere high containment infectious disease facilities to test its Firefly UV device for the ICU and hospitals with 2019-nCoV (the COVID-19 virus). The preliminary results show that PuraCath’s device has achieved 99.9999% disinfection with SARS-CoV-2 (the virus that is […]
PuraCath FireflyTM Can Kill Deadly Microorganisms with UV Light, Like SARS CoV-2
President Trump has officially declared a national emergency. A novel coronavirus has been identified in Wuhan City, China and has spread worldwide. It has been named SARS CoV-2 (causing disease COVID-19) by WHO. SARS CoV-2 has officially become a global pandemic by WHO. There have already been over 170,000 confirmed cases to date with an […]
PuraCath Medical Shows Greater Than 99.99% Reduction in ‘Superbug’ Candida Auris with One Second of UVC Exposure
JUNE 18, 2019 PuraCath Medical, a venture-backed medical device company based in Silicon Valley, announced today that it has achieved 99.99% disinfection on its vascular access Firefly disinfection technology system with Candida auris (‘superbug’), Staphylococcus aureus, and Candida albicans. “Achieving greater than 4 log disinfection in these virulent microbes with only one second of UV […]
PuraCath Medical Shows Significant Reduction in Causes of Peritonitis in Peritoneal Dialysis International Journal
San Francisco, California (March 7, 2017) – PuraCath Medical has published the result of its recent research on its ultraviolet (UV) light-based peritoneal dialysis catheter connection system in Peritoneal Dialysis International (PDI), the official Journal of the International Society for Peritoneal Dialysis. PDI is a major source of knowledge in the field of peritoneal dialysis and aims […]
PuraCath Medical to Present Data on FireFly™ Peritoneal Dialysis Connector Disinfecting System during 53rd ERA-EDTA Congress
San Francisco, California (May 12, 2016) – Data being presented will support planned introduction of PuraCath Medical’s technology in the European Union. PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it will present data on its next generation version of the FireFly™ […]
PuraCath Medical Presents Data at National Kidney Foundation 2016 Spring Clinical Meetings
Boston, Massachusetts (April 28, 2016) – PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it presented data on its next generation version of the FireFly™ Peritoneal Dialysis (PD) Connector Disinfecting System during the National Kidney Foundation’s 2016 Spring Clinical Meetings held […]
PuraCath Medical Presents New Research Data during 36th Annual Dialysis Conference
Company presents study on the effectiveness of next-generation version of the FireFly™ Peritoneal Dialysis Connector Disinfecting System Seattle, Washington (February 29, 2016) – PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it presented data on its next generation version of […]
PuraCath Medical Receives 510(k) Clearance for the FireFly™ Peritoneal Dialysis Connector Disinfecting System
PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, announced today that it has received 510(k) clearance for its FireFly™ Peritoneal Dialysis Connector Disinfecting System from the U.S. Food and Drug Administration (FDA). This regulatory determination by the FDA gives PuraCath clearance to market […]
The MedTech Strategist: PuraCath Medical, Anti-infection Device Enables Greater Access to Peritoneal Dialysis
We are excited to announce that PuraCath Medical is listed as a start-up to watch in the latest volume of the MedTech Strategist published on October 16th. Please read the full article here.
PuraCath Medical Presents Data on the Company’s Proprietary Infection Reduction Technology during the National Science Foundation’s SBIR Phase II Grantee Conference
Atlanta, Georgia (June 2, 2015) – PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients on dialysis therapy, announced today that the company was a featured presenter during the National Science Foundation’s (NSF) Small Business Innovation Research (SBIR) 2015 Phase II Grantee Conference held in Atlanta, Georgia. PuraCath presented […]
PuraCath Medical Presents Study at National Kidney Foundation 2015 Spring Clinical Meetings
Company presents new data on the effectiveness of UV light to purify peritoneal dialysis catheter connections across a wider range of microorganisms that contribute to infections in PD patients Dallas, Texas (March 27, 2015) – PuraCath Medical, an emerging company in the development of technologies to reduce infections in patients with intravascular and peritoneal catheters, […]
PuraCath Medical Presents Data at 2014 Annual Meeting of the American Society of Nephrology
Company presents study on the effectiveness of UV light to purify peritoneal dialysis catheter connections PuraCath Medical, an emerging company in the development of technologies to reduce infections in dialysis patients, announced today that it presented scientific data during Kidney Week 2014 demonstrating the ability to reduce bacterial growth in a simulated peritoneal dialysis delivery […]
KHI stakeholders conference 2014 – June 11-12, 2014
To advance scientific understanding of the kidney health and patient safety implications of new and existing medical products and to foster development of therapies for diseases that affect the kidney by creating a collaborative environment in which FDA and the greater nephrology community can interact to optimize evaluation of drugs, devices, biologics, and food products.
PuraCath Medical presents with booth at BIO 2014 conference under SBIR Innovation Zone
The 2014 BIO International Convention is June 23-26 at the San Diego Convention Center in San Diego, California. BIO 2014 conference under SBIR Innovation Zone
PuraCath Medical, Inc. Awarded NSF Grant
PuraCath Medical, Inc. Awarded NSF (National Science Foundation) SBIR Phase I Grant for Developing Innovative Catheter Design for PD Patients.
PuraCath Medical, Inc. Awarded NSF SBIR Phase II Grant
PuraCath Medical, Inc. Awarded NSF SBIR Phase II Grant for Novel Peritoneal Dialysis Catheter to Reduce Infections.